IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.506
AS - Asia 7.948
EU - Europa 5.559
SA - Sud America 1.238
AF - Africa 163
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 7
Totale 41.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.310
SG - Singapore 3.634
CN - Cina 1.662
UA - Ucraina 1.377
BR - Brasile 992
IT - Italia 975
HK - Hong Kong 869
DE - Germania 762
SE - Svezia 653
VN - Vietnam 628
TR - Turchia 488
RU - Federazione Russa 369
FR - Francia 319
IE - Irlanda 276
FI - Finlandia 252
GB - Regno Unito 215
IN - India 166
AR - Argentina 102
BD - Bangladesh 99
NL - Olanda 88
CA - Canada 76
MX - Messico 74
IQ - Iraq 58
JP - Giappone 53
AT - Austria 50
ZA - Sudafrica 44
PL - Polonia 42
EC - Ecuador 40
BE - Belgio 37
PK - Pakistan 36
CO - Colombia 28
ES - Italia 28
EU - Europa 25
SA - Arabia Saudita 25
ID - Indonesia 24
KR - Corea 24
UZ - Uzbekistan 24
CZ - Repubblica Ceca 20
CL - Cile 19
JO - Giordania 19
MA - Marocco 19
PE - Perù 19
KE - Kenya 18
PH - Filippine 17
RS - Serbia 14
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
PY - Paraguay 12
VE - Venezuela 12
IR - Iran 11
TN - Tunisia 11
BO - Bolivia 10
DZ - Algeria 10
LT - Lituania 10
DO - Repubblica Dominicana 9
JM - Giamaica 9
KZ - Kazakistan 9
NP - Nepal 9
CH - Svizzera 8
ET - Etiopia 8
RO - Romania 8
TH - Thailandia 8
AO - Angola 7
LV - Lettonia 7
DK - Danimarca 6
EG - Egitto 6
HU - Ungheria 6
IL - Israele 6
LB - Libano 6
MY - Malesia 6
OM - Oman 6
BG - Bulgaria 5
CR - Costa Rica 5
GH - Ghana 5
PT - Portogallo 5
AM - Armenia 4
GR - Grecia 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AU - Australia 3
BW - Botswana 3
CY - Cipro 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
LK - Sri Lanka 3
MM - Myanmar 3
MN - Mongolia 3
MZ - Mozambico 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
Totale 41.391
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.254
Ashburn 2.083
Ann Arbor 1.932
Singapore 1.534
Seattle 1.470
Chandler 1.364
Wilmington 1.309
Cambridge 1.302
Hong Kong 851
Dearborn 815
Beijing 741
Jacksonville 687
Izmir 453
Boardman 433
San Jose 398
Princeton 300
Dublin 273
Lauterbourg 270
Los Angeles 204
Udine 190
Council Bluffs 181
San Diego 175
Des Moines 166
Dong Ket 158
Ho Chi Minh City 151
Dallas 141
Redondo Beach 118
Buffalo 112
Hanoi 107
Falls Church 94
São Paulo 88
Milan 84
New York 82
Andover 74
Hefei 68
Frankfurt am Main 67
Norwalk 64
Munich 63
Santa Clara 58
Nanjing 55
Ogden 51
Helsinki 50
The Dalles 49
Tokyo 47
Rome 46
Phoenix 45
Guangzhou 40
Kunming 40
Brussels 37
Warsaw 37
Orem 36
Nuremberg 35
Rio de Janeiro 33
Shanghai 33
Redmond 32
Chennai 30
Chicago 30
Grafing 30
Jinan 28
London 27
Trieste 27
Fuzhou 26
Montreal 26
Baghdad 25
Atlanta 24
Johannesburg 24
Vienna 24
Belo Horizonte 23
Brooklyn 23
Haiphong 22
Mexico City 21
Mumbai 21
Turin 21
Amsterdam 20
Bologna 20
Denver 20
Fremont 20
Naples 20
Toronto 20
Stockholm 19
Tashkent 19
Curitiba 18
Da Nang 18
Quito 18
Redwood City 18
Amman 17
Nanchang 17
Venezia 17
Zhengzhou 17
Brno 16
Buenos Aires 16
Dhaka 16
San Francisco 16
Wuhan 16
Boston 15
Brasília 15
Istanbul 15
Palermo 15
Totale 29.484
Salva come PNG Salva come JPEG
Nome #
Terapia e profilassi delle infezioni 405
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 277
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 257
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 247
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 245
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 243
The management of multidrug-resistant enterobacteriaceae 242
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 226
Delafloxacin for the treatment of respiratory and skin infections 219
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 215
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 210
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 205
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 203
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 199
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 197
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 193
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 190
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 186
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 186
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 184
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 183
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 183
Advances in antibiotic therapy in the critically ill 182
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 181
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 180
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 179
New therapeutic options for respiratory tract infections 178
Safety of long-term use of linezolid: Results of an open-label study 177
Hot topics in necrotising skin and soft tissue infections 177
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 177
An Italian consensus for invasive candidiasis management (ITALIC) 176
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 176
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 175
Ceftolozane/tazobactam: place in therapy 175
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 174
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 173
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 173
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 173
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 172
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 172
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 172
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 172
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 171
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 171
Impact of new treatment options for hepatitis c virus infection in liver transplantation 171
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 170
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 170
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 169
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 169
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 169
Different miRNA expression in transplanted livers of HCV mono-infected and HCV/HIV co-infected recipients 169
Current and future therapies for invasive aspergillosis 168
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 168
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 168
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 168
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 167
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 167
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 167
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 166
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 166
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 166
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 165
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 165
A survey on infection management practices in Italian ICUs 165
New therapeutic options for skin and soft tissue infections 165
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 164
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 164
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 164
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 163
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 163
Linezolid underexposure in a patient co-treated with venlafaxine 162
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 161
Development of novel antibacterial drugs to combat multiple resistant organisms 161
The role of dalbavancin in skin and soft tissue infections 161
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? 161
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 161
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 160
Eravacycline for the treatment of intra-abdominal infections 160
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 159
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 159
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 159
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 158
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 158
Epidemiology and predictors of recurrence of Clostridium difficile infection in a North Italian tertiary care hospital 156
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 156
Intensive care unit patients with lower respiratory tract nosocomial infections: The ENIRRIs project 156
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 155
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 155
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 155
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 155
Designing a pathogen-focused study to address the high unmet medical need represented by carbapenem-resistant gram-negative pathogens – the international, multicenter, randomized, open-label, phase 3 credible-cr study 155
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 154
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 154
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal 154
Prosthetic joints: Shining lights on challenging blind spots 154
Immunological profiles of HIV-positive recipients of liver transplant 154
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 154
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 154
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 153
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 153
Totale 17.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021482 0 0 0 0 0 0 0 0 0 0 0 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20254.553 137 357 226 220 138 259 221 354 565 405 457 1.214
2025/20268.355 646 908 680 665 1.424 888 1.165 304 542 647 433 53
Totale 42.679